Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease

Keyphrases

• Clinical Trials 100%
• Regurgitation 100%
• Gastroesophageal Reflux Disease 100%
• Proton Pump Inhibitor Therapy 100%
• Heartburn 33%
• Placebo 16%
• Placebo-controlled Trial 16%
• Inhibitor Treatment 16%
• Proton Pump Inhibitors 16%
• Therapeutic Gain 16%
• Treatment Response 8%
• Inconsistency 8%
• Drug Response 8%
• Meta-analysis 8%
• Method Study 8%
• Entry Criteria 8%
• PubMed 8%
• Positive Treatment 8%
• Embase 8%
• Response Assessment 8%
• Patient-reported Instruments 8%
• Clinical Reports 8%
• Incomplete Response 8%
• Placebo Response Rate 8%
• Typical Symptoms 8%
• Cochrane Review 8%
• Histamine-2 Receptor Antagonists (H2RA) 8%

Medicine and Dentistry

• Gastroesophageal Reflux 100%
• Proton-Pump Inhibitor 100%
• Clinical Trial 100%
• Heartburn 66%
• Placebo 66%
• Treatment Response 16%
• Meta-Analysis 16%
• Drug Response 16%
• H2 Antagonist 16%
• Placebo Effect 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Gastroesophageal Reflux 100%
• Proton Pump Inhibitor 100%
• Placebo 83%
• Heartburn 66%
• Histamine H2 Receptor Antagonist 16%